The Mentor Capital Cancer Immunotherapy Index ©

* Cancer Immunotherapy Index developed
with Mike Havrilla, PhD., Editor of BioMedReports.com, as a sub-set to his Cancer Diagnostic &
Therapeutic Micro-Cap Index.
** Reflects Market Cap of Mentor Capital with 100% of
Quantum Immunologics.
*** Market Data from National Cancer Institute based on
Relative Mortality in company treatment areas & 50% penetration by immunotherapy sector into cancer
treatments.
Click to see larger
|